| Product NDC: | 0009-4709 |
| Proprietary Name: | Depo-SubQ Provera |
| Non Proprietary Name: | medroxyprogesterone acetate |
| Active Ingredient(s): | 104 mg/.65mL & nbsp; medroxyprogesterone acetate |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-4709 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021583 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050502 |
| Package NDC: | 0009-4709-13 |
| Package Description: | .65 mL in 1 SYRINGE (0009-4709-13) |
| NDC Code | 0009-4709-13 |
| Proprietary Name | Depo-SubQ Provera |
| Package Description | .65 mL in 1 SYRINGE (0009-4709-13) |
| Product NDC | 0009-4709 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | medroxyprogesterone acetate |
| Dosage Form Name | INJECTION, SUSPENSION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20050502 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | MEDROXYPROGESTERONE ACETATE |
| Strength Number | 104 |
| Strength Unit | mg/.65mL |
| Pharmaceutical Classes | Progesterone Congeners [Chemical/Ingredient],Progestin [EPC] |